Aperio Group’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $65K | Buy |
1,077
+19
| +2% | +$1.15K | ﹤0.01% | 2400 |
|
|
2020
Q3 | $84K | Sell |
1,058
-594
| -36% | -$47.2K | ﹤0.01% | 2329 |
|
|
2020
Q2 | $103K | Buy |
1,652
+760
| +85% | +$47.4K | ﹤0.01% | 2272 |
|
|
2020
Q1 | $47K | Sell |
892
-3
| -0.3% | -$158 | ﹤0.01% | 2280 |
|
|
2019
Q4 | $109K | Sell |
895
-81
| -8% | -$9.87K | ﹤0.01% | 2255 |
|
|
2019
Q3 | $178K | Buy |
976
+384
| +65% | +$70K | ﹤0.01% | 2185 |
|
|
2019
Q2 | $77K | Buy |
592
+276
| +87% | +$35.9K | ﹤0.01% | 2457 |
|
|
2019
Q1 | $78K | Buy |
316
+50
| +19% | +$12.3K | ﹤0.01% | 2253 |
|
|
2018
Q4 | $51K | Sell |
266
-52
| -16% | -$9.97K | ﹤0.01% | 2259 |
|
|
2018
Q3 | $104K | Sell |
318
-37
| -10% | -$12.1K | ﹤0.01% | 2250 |
|
|
2018
Q2 | $111K | Sell |
355
-455
| -56% | -$142K | ﹤0.01% | 2218 |
|
|
2018
Q1 | $197K | Buy |
810
+138
| +21% | +$33.6K | ﹤0.01% | 2146 |
|
|
2017
Q4 | $203K | Sell |
672
-13
| -2% | -$3.93K | ﹤0.01% | 2137 |
|
|
2017
Q3 | $181K | Buy |
685
+14
| +2% | +$3.7K | ﹤0.01% | 2133 |
|
|
2017
Q2 | $177K | Sell |
671
-15
| -2% | -$3.96K | ﹤0.01% | 2126 |
|
|
2017
Q1 | $247K | Buy |
686
+185
| +37% | +$66.6K | ﹤0.01% | 1924 |
|
|
2016
Q4 | $145K | Buy |
501
+20
| +4% | +$5.79K | ﹤0.01% | 2050 |
|
|
2016
Q3 | $163K | Buy |
+481
| New | +$163K | ﹤0.01% | 1980 |
|
|
2014
Q4 | – | Sell |
-270
| Closed | -$63K | – | 1907 |
|
|
2014
Q3 | $63K | Buy |
+270
| New | +$63K | ﹤0.01% | 1712 |
|